Cosmos Health Inc (COSM)

$1.24

-0.01

(-1.2%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $1.19
    $1.30
    $1.24
    downward going graph

    4.03%

    Downside

    Day's Volatility :8.45%

    Upside

    4.61%

    downward going graph
  • $0.47
    $2.12
    $1.24
    downward going graph

    62.28%

    Downside

    52 Weeks Volatility :77.94%

    Upside

    41.51%

    downward going graph

Returns

PeriodCosmos Health IncIndex (Russel 2000)
3 Months
159.4%
0.0%
6 Months
16.2%
0.0%
1 Year
-49.4%
0.0%
3 Years
-98.54%
-17.0%

Highlights

Market Capitalization
21.1M
Book Value
$3.4
Earnings Per Share (EPS)
-4.23
PEG Ratio
0.0
Wall Street Target Price
4.0
Profit Margin
-31.48%
Operating Margin TTM
-23.53%
Return On Assets TTM
-16.58%
Return On Equity TTM
-62.79%
Revenue TTM
49.6M
Revenue Per Share TTM
5.07
Quarterly Revenue Growth YOY
6.7%
Gross Profit TTM
8.3M
EBITDA
-15.3M
Diluted Eps TTM
-4.23
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.64
EPS Estimate Next Year
-0.47
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Cosmos Health Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 222.58%

Current $1.24
Target $4.00

Company Financials

FY18Y/Y Change
Revenue
37.1M
↑ 23.56%
Net Income
-9.1M
↑ 45.91%
Net Profit Margin
-24.43%
↓ 3.74%
FY19Y/Y Change
Revenue
39.7M
↑ 6.99%
Net Income
-3.3M
↓ 63.59%
Net Profit Margin
-8.31%
↑ 16.12%
FY20Y/Y Change
Revenue
55.4M
↑ 39.65%
Net Income
820.8K
↓ 124.88%
Net Profit Margin
1.48%
↑ 9.79%
FY21Y/Y Change
Revenue
56.2M
↑ 1.5%
Net Income
-8.0M
↓ 1070.0%
Net Profit Margin
-14.16%
↓ 15.64%
FY22Y/Y Change
Revenue
50.3M
↓ 10.48%
Net Income
-13.8M
↑ 73.71%
Net Profit Margin
-27.47%
↓ 13.31%
FY23Y/Y Change
Revenue
49.6M
↓ 1.51%
Net Income
-15.6M
↑ 12.87%
Net Profit Margin
-31.48%
↓ 4.01%
Q2 FY22Q/Q Change
Revenue
13.2M
↓ 18.36%
Net Income
-1.2M
↓ 15.68%
Net Profit Margin
-9.4%
↓ 0.3%
Q3 FY22Q/Q Change
Revenue
12.0M
↓ 9.03%
Net Income
-2.0M
↑ 58.93%
Net Profit Margin
-16.42%
↓ 7.02%
Q4 FY22Q/Q Change
Revenue
12.1M
↑ 0.29%
Net Income
-10.8M
↑ 448.45%
Net Profit Margin
-89.78%
↓ 73.36%
Q1 FY23Q/Q Change
Revenue
12.1M
↑ 0.0%
Net Income
-10.8M
↑ 0.0%
Net Profit Margin
-89.78%
↑ 0.0%
Q2 FY23Q/Q Change
Revenue
12.4M
↑ 2.59%
Net Income
-981.5K
↓ 90.93%
Net Profit Margin
-7.94%
↑ 81.84%
Q3 FY23Q/Q Change
Revenue
12.8M
↑ 3.72%
Net Income
-3.3M
↑ 241.22%
Net Profit Margin
-26.12%
↓ 18.18%
FY17Y/Y Change
Total Assets
10.7M
↑ 242.33%
Total Liabilities
13.7M
↑ 181.31%
FY18Y/Y Change
Total Assets
20.7M
↑ 93.85%
Total Liabilities
24.0M
↑ 75.23%
FY19Y/Y Change
Total Assets
23.9M
↑ 15.39%
Total Liabilities
30.3M
↑ 26.35%
FY20Y/Y Change
Total Assets
43.8M
↑ 83.61%
Total Liabilities
48.0M
↑ 58.22%
FY21Y/Y Change
Total Assets
49.4M
↑ 12.74%
Total Liabilities
45.0M
↓ 6.16%
FY22Y/Y Change
Total Assets
68.0M
↑ 37.65%
Total Liabilities
28.4M
↓ 37.0%
Q2 FY22Q/Q Change
Total Assets
47.8M
↓ 3.21%
Total Liabilities
39.7M
↓ 11.9%
Q3 FY22Q/Q Change
Total Assets
45.6M
↓ 4.64%
Total Liabilities
40.5M
↑ 1.96%
Q4 FY22Q/Q Change
Total Assets
68.0M
↑ 49.14%
Total Liabilities
28.4M
↓ 29.86%
Q1 FY23Q/Q Change
Total Assets
68.0M
↑ 0.0%
Total Liabilities
28.4M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
68.6M
↑ 0.81%
Total Liabilities
24.6M
↓ 13.5%
Q3 FY23Q/Q Change
Total Assets
71.5M
↑ 4.28%
Total Liabilities
27.0M
↑ 9.8%
FY18Y/Y Change
Operating Cash Flow
-1.6M
↓ 82.25%
Investing Cash Flow
-195.8K
↑ 1252.11%
Financing Cash Flow
2.0M
↓ 78.6%
FY19Y/Y Change
Operating Cash Flow
-4.8M
↑ 207.9%
Investing Cash Flow
588.9K
↓ 400.82%
Financing Cash Flow
3.6M
↑ 80.42%
FY20Y/Y Change
Operating Cash Flow
-11.5M
↑ 140.18%
Investing Cash Flow
-117.7K
↓ 119.99%
Financing Cash Flow
12.5M
↑ 247.35%
FY21Y/Y Change
Operating Cash Flow
-7.1M
↓ 38.29%
Investing Cash Flow
-826.8K
↑ 602.22%
Financing Cash Flow
7.3M
↓ 41.67%
Q2 FY22Q/Q Change
Operating Cash Flow
-686.4K
↓ 55.66%
Investing Cash Flow
-247.5K
↓ 383.79%
Financing Cash Flow
558.8K
↓ 29.48%
Q3 FY22Q/Q Change
Operating Cash Flow
-1.5M
↑ 122.7%
Investing Cash Flow
91.4K
↓ 136.91%
Financing Cash Flow
1.0M
↑ 79.8%
Q4 FY22Q/Q Change
Operating Cash Flow
-5.7M
↑ 274.18%
Investing Cash Flow
-4.0M
↓ 4435.13%
Financing Cash Flow
2.2M
↑ 123.24%
Q1 FY23Q/Q Change
Operating Cash Flow
-10.3M
↑ 80.39%
Investing Cash Flow
-4.5M
↑ 13.26%
Financing Cash Flow
30.6M
↑ 1263.05%
Q2 FY23Q/Q Change
Operating Cash Flow
-5.7M
↓ 44.57%
Investing Cash Flow
-4.0M
↓ 11.71%
Financing Cash Flow
-184.2K
↓ 100.6%

Technicals Summary

Sell

Neutral

Buy

Cosmos Health Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cosmos Health Inc
Cosmos Health Inc
74.55%
16.2%
-49.4%
-98.54%
-98.54%
Cardinal Health, Inc.
Cardinal Health, Inc.
-8.69%
-9.65%
3.42%
70.12%
111.82%
Cencora Inc
Cencora Inc
-5.08%
2.49%
25.05%
62.54%
96.12%
Mckesson Corporation
Mckesson Corporation
-4.11%
19.36%
40.74%
206.99%
316.44%
Henry Schein, Inc.
Henry Schein, Inc.
6.19%
-4.55%
-11.06%
-4.24%
4.7%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cosmos Health Inc
Cosmos Health Inc
NA
NA
0.0
-0.64
-0.63
-0.17
NA
3.4
Cardinal Health, Inc.
Cardinal Health, Inc.
42.46
42.46
0.31
7.36
0.0
0.03
0.02
-13.38
Cencora Inc
Cencora Inc
23.39
23.39
1.58
11.93
2.34
0.03
0.01
3.39
Mckesson Corporation
Mckesson Corporation
25.97
25.97
4.96
27.59
0.0
0.04
0.0
-15.16
Henry Schein, Inc.
Henry Schein, Inc.
23.98
23.98
1.65
5.07
0.08
0.04
NA
28.02
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cosmos Health Inc
Cosmos Health Inc
Buy
$21.1M
-98.54%
NA
-31.48%
Cardinal Health, Inc.
Cardinal Health, Inc.
Hold
$23.4B
111.82%
42.46
0.25%
Cencora Inc
Cencora Inc
Buy
$38.5B
96.12%
23.39
0.66%
Mckesson Corporation
Mckesson Corporation
Buy
$75.5B
316.44%
25.97
0.97%
Henry Schein, Inc.
Henry Schein, Inc.
Hold
$9.1B
4.7%
23.98
3.12%

Insights on Cosmos Health Inc

  • Increasing Revenue

    Revenue is up for the last 5 quarters, 12.01M → 12.82M (in $), with an average increase of 1.6% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -981.53K → -3.34M (in $), with an average decrease of 241.2% per quarter

  • Vs MCK

    In the last 1 year, Mckesson Corporation has given 40.7% return, outperforming this stock by 90.1%

Institutional Holdings

  • BlackRock Inc

    1.73%
  • Vanguard Group Inc

    0.80%
  • Geode Capital Management, LLC

    0.61%
  • State Street Corporation

    0.15%
  • Northern Trust Corp

    0.12%
  • HRT FINANCIAL LLC

    0.07%

Company Information

Organization
Cosmos Health Inc
Employees
102
CEO
Mr. Grigorios Siokas
Industry
Miscellaneous

FAQs